Facts & figures
Our track record
- 1100 patents filed in the past 20 years
- 21 staff-led startups in the past 10 years
- 19 commercialisation deals in 2018
Our portfolio of inventions and innovations spans a number of sectors, including diagnostics, therapeutics, biomedical devices and optical technology, just to name a few.
The value of oyster aquaculture globally exceeds US$3.9 billion, however vulnerabilities to some pathogens and viruses are reducing shellfish yields.
In particular, the pathogen ostreid herpesvirus-1 has severely disrupted Pacific oyster production in Europe since 2008, and in New Zealand and Australia since 2010.
Other pathogens such as Martellia sp. and Bonamia sp. are prevalent globally and impact filter-feeding shellfish such as oysters and mussels in many countries.
There are no established methods to prevent these diseases, and consequently the shellfish industry is plagued by recurrent outbreaks and economic losses.
Our technology consists of a protective fabric that is inserted into a conventional shellfish basket, tray or pillow.
The membrane has pores of a specific size that allow water to pass through, and exclude particles such as parasites and herpes viruses.
The behaviour of grain during industrial processes is a key element of effective malt extract production and hence, beer making. With the current exponential growth of craft brewers around the world, it’s even more important!
The aleurone layer of mature cereal grains has a critical role in germination. Isolation of aleurone layer protoplasts enables flexibility in the investigation of biochemical processes that occur in the aleurone layer of grains during grain development, germination and malting.
However current methods to isolate aleurone layer protoplasts only work with a specific huskless barley variety, not with commercial malting barley varieties used in industry.
Associate Professor Thomas Roberts and his team have developed a protocol for obtaining barley aleurone layer protoplasts from commercial malting varieties in a reproducible manner. This protocol is useful to predict the behaviour of germinating barley grain during malting.
Our researchers have developed an extraction protocol for barley aleurone layer protoplasts from commercial barley malting varieties. Studies show that the proteins of protoplasts can be extracted, analysed and compared at different time points during their culture. The direct study of the barley aleurone layer can be facilitated by the use of protoplasts as they can be more accurately controlled, treated and monitored than the whole aleurone.
Preliminary data has shown that the protoplasts respond to exposure to plant hormones such as gibberellic acid and abscisic acid, in the same way as the intact aleurone layer.
The protoplast extraction protocol allows:
Use of the extraction protocol for barley aleurone layer protoplasts in a commercial process could:
Professor Salah Sukkarieh from the Australian Centre for Field Robotics in the Faculty of Engineering and his team have developed several novel robots and robotic systems that can be used to improve efficiencies in agriculture.
Awarded the NSW Science and Engineering Award for Excellence in Engineering and Information and Communications Technologies in 2014, Professor Sukkarieh is an international expert in the research, development and commercialisation of field robotic systems.
Agriculture is increasingly under pressure to increase efficiency and plant yield. Our robotic solutions can help overcome both of these issues.
Our automated robotic systems allow:
The robots can also be customised for other applications.
We offer flexible licensing agreements, to streamline the process for our partner organisations.
If you’d like to find out more about the intellectual property we have available for licencing, or our range of licensing options, contact us on +61 2 9351 4000 or via our enquiry form.
We're affiliated with a number of startups and new venture projects that have spun out from our technologies.
Elastagen Pty Ltd is a clinical-stage medical device company that is pioneering Elastatherapy, which uses the human protein elastin to naturally repair and augment the skin.
The company has arisen out of patented research conducted by Professor Tony Weiss’s group and the first clinical trials have demonstrated the biocompatibility and safety of their synthetic human elastin in human subjects.
Breathe Well is an interactive medical device company to assist lung cancer patients to breathe well, facilitating stable lung tumour motion for accurate radiation delivery during cancer treatment. The company was founded by Professor Paul Keall based on his work at the University of Sydney and Stanford University.